Company Dynamic

On December 16, Dawn Company Limited announced in a statement its plan to utilize its own funds for the renovation and expansion of an existing project.

In recent years, pharmaceutical companies have increasingly relied on external contractors for drug testing and production. Novo Nordisk's parent company, Novo Holdings, announced the acquisition of major contract manufacturer Catalent for $16.5 billion,

On December 13, McKinsey signed the agreement in the Federal Court of Virginia, stipulating that if McKinsey pays $650 million and meets a series of conditions over the next five years—such as refraining from providing sales, marketing, and promotion serv

On December 16, Innovent Biologics and Eli Lilly announced a collaboration agreement for the non-covalent (reversible) Bruton’s tyrosine kinase (BTK) inhibitor, pirtobrutinib, in mainland China.

Evonik operates in over 100 countries worldwide. In the 2023 fiscal year, the company achieved €15.3 billion in sales and an adjusted EBITDA of €1.66 billion, employing more than 33,000 people globally.

Last week, on December 13, Nippon Paint Decorative Materials (Guangzhou) Co., Ltd. officially released a price adjustment notice. The notice stated that due to the continued rise in costs of key raw materials such as titanium dioxide, resins, and emulsion

BASF's new cosmetic ingredient Symbiocell from the Personal Care business has been successfully registered in China. With BASF's authorization, the product can be commercialized as a cosmetic ingredient in China.

• BASF

Lucas Meyer Cosmetics by Clariant has announced the opening of its new Beauty ColLABoration House near Los Angeles, California.

• Clariant
• Lucas Meyer Cosmetics

Clariant is expanding its Cangzhou production plant to produce the multifunctional additive Nylostab S-EED.

• Clariant
• additive

According to a statement released by China National Offshore Oil Corporation on the 14th, the company has sold its US subsidiary together with its upstream oil and gas assets in the Gulf of Mexico to British chemical group INEOS.

• CNOOC
• INEOS

Dow has announced that cutting-edge polyether polyol VORANOL WK5750 will be produced at its Freeport Polyols Plant, marking its continued commitment to high application performance.

• Dow
• VORANOL WK5750

Pañpuri, a Thai luxury fragrance brand, has been acquired by Japan's renowned cosmetics group KOSÉ Group and is now preparing to expand its global presence in the luxury market.

• Pañpuri
• KOSÉ

BASF (China) Co., Ltd. and Bosch Automotive Technology Service (Beijing) Co., Ltd. (RBTS) jointly signed a memorandum of understanding at the Shanghai Frankfurt Auto Parts Show to cooperate on the automotive aftermarket business.

• BASF
• RBTS
• automotive refinish paint

The AstraZeneca employee fraud case involves sales personnel in China who allegedly forged or altered tumor gene testing reports to defraud the national Medicare fund, particularly concerning AstraZeneca's lung cancer treatment drug, Tagrisso.

Starbucks CEO Takafumi Mizuguchi stated: "We have listened carefully to our customers' feedback on their drinking experience and conducted in-depth research and improvements. In the future, we will continue to accelerate our business activities related to

As for the 20GWh project in Morocco, it will be implemented by Guoxuan's registered holding subsidiary, Gotion Power Morocco S.A., established on July 12, 2024. This project is also planned to be phased, with completion expected within five years, with sp

ExxonMobil (XOM) unveiled an ambitious plan to increase its oil and gas production by 18% by 2030, which will be driven by annual project spending ranging from $28 billion to $33 billion between 2026 and 2030.

• ExxonMobil

On December 12, 2024, BASF officially opened its new catalyst development and solid processing center in Ludwigshafen, Germany.

• BASF

Azelis, a leading innovative service provider to the specialty chemicals and food ingredients industries, is pleased to announce a new distribution agreement with AAK.

• Azelis
• AAK

Recently, investigations by the UK’s Prescription Medicines Code of Practice Authority (PMCPA) have put pharmaceutical giants AstraZeneca and GlaxoSmithKline (GSK) in the spotlight. This incident not only reveals the strictness of compliance overseas but